Skip to main content
Clinical Trials/NCT01947270
NCT01947270
Completed
Not Applicable

OPMED STUDY: Multidisciplinary Program "Optimization of Drug Prescription" : Impact on the Quality of Drug Prescription in Hospitalized Elderly Patients

Hospices Civils de Lyon1 site in 1 country3,055 target enrollmentJanuary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Potentially Inappropriate Medications
Sponsor
Hospices Civils de Lyon
Enrollment
3055
Locations
1
Primary Endpoint
Proportion of potentially inappropriate medications (PIM) prescribed in discharge of hospitalized patients from 75 years old.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Drug prescription is a fundamental component of care for the elderly. Even if drugs are a chance for the older patient, because of changes in pharmacological, pharmacokinetic and pharmacodynamic parameters related with age and acute/or chronic pathologies, the risks associated with drug prescription, particularly those associated with potentially inappropriate medication (PIM), are increased in the elderly.

We suppose that many of hospitalized elderly have at least one prescribed medication without valid indication. Conversely, many diseases are currently undertreated in elderly patients: e.g. medicines used to treat heart failure and osteoporosis are underused in 20 to 70% of patients. Moreover, PMI prescription is associated with an increased of morbidity, mortality, risk of drug-related adverse events, utilization of health care system, care costs and impairment of quality of life. Thus, optimization of drug prescription is a major concern for improvement of the quality and safety of care in elderly.

The investigators' hypothesis is that a multidisciplinary program entitled "Optimisation de la Prescription MEDicamenteuse" ("Optimization of drug prescribing") focused on drug prescription optimization including a physician training to the specificity of the drug prescription in the elderly and a checklist allowing an adapted and standardized pharmaceutical analysis is effective in reducing PIM in elderly patients hospitalized in short-term medical and geriatric care departments.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
June 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female subject aged over 75 years hospitalized in one of the participating department
  • Patient agreed to participate

Exclusion Criteria

  • Patient with a predictive length of stay equal or less than 48 hours
  • Patients admitted in terminal illness

Outcomes

Primary Outcomes

Proportion of potentially inappropriate medications (PIM) prescribed in discharge of hospitalized patients from 75 years old.

Time Frame: at discharge (average 3 weeks)

Proportion of prescribed PIM will be expressed as the ratio of PIM to the total number of medication in discharge prescription sheet. PIM will be identified by 2 experts (1 doctor and 1 pharmacist) based on criteria from the lists STOPP/START and Laroche.

Secondary Outcomes

  • Total number of drugs prescribed per discharge prescription sheet(at discharge (average 3 weeks))
  • Number of emergency admission within 12 months following hospitalization(12 months after inclusion)
  • Number of rehospitalization within 12 months following discharge(12 months after inclusion)
  • Mortality within 12 months after hospitalization(12 months after inclusion)

Study Sites (1)

Loading locations...

Similar Trials